Direct-to-brain chemo better than systemic drugs when immunotherapy is to follow – Science Daily
|
Direct-to-brain chemo better than systemic drugs when immunotherapy is to follow
Science Daily Lim's laboratory in neurosurgery and a team from the Bloomberg~Kimmel Institute for Cancer Immunotherapy led by Drew Pardoll, M.D., Ph.D., performed their studies in a mouse with glioblastoma. In people, glioblastoma is a particularly aggressive form … |
